Science Explorer Back to mapMap

Most cited papers in Infectious Diseases

What are the most cited papers in Infectious Diseases?

The most cited paper in Infectious Diseases is "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China" (Chaolin Huang et al., 2020), with 52,028 citations. Next come "Clinical Characteristics of Coronavirus Disease 2019 in China" (31,256) and "A Novel Coronavirus from Patients with Pneumonia in China, 2019" (30,499).

Showing 50 of 99 papers. Every paper with more than 4,866 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Chaolin Huang et al. · The Lancet Open access 24 Jan 2020 52,028
2 Clinical Characteristics of Coronavirus Disease 2019 in China Wei‐jie Guan et al. · New England Journal of Medicine Open access 28 Feb 2020 31,256
3 A Novel Coronavirus from Patients with Pneumonia in China, 2019 Na Zhu, Dingyu Zhang, Wenling Wang et al. · New England Journal of Medicine Open access 24 Jan 2020 30,499
4 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet Open access Mar 2020 29,236
5 AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility Garrett M. Morris, Ruth Huey, William Lindstrom et al. · Journal of Computational Chemistry Open access 27 Apr 2009 25,864
6 A pneumonia outbreak associated with a new coronavirus of probable bat origin Peng Zhou et al. · Nature Open access 3 Feb 2020 23,429
7 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Nanshan Chen, Min Zhou, Xuan Dong et al. · The Lancet Open access 30 Jan 2020 22,766
8 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder et al. · Cell Open access 8 Mar 2020 21,493
9 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China Dawei Wang, Bo Hu, Chang Hu et al. · JAMA Open access 7 Feb 2020 21,261
10 La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19 Martínez González, Marina · DSPACE System - Metalibrary (University of the Coast) Open access 2020 19,306
11 Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Zunyou Wu, Jennifer M. McGoogan · JAMA Open access 24 Feb 2020 18,071
12 Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia Qun Li et al. · New England Journal of Medicine Open access 29 Jan 2020 18,005
13 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine Fernando P. Polack et al. · New England Journal of Medicine Open access 10 Dec 2020 15,741
14 Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Anna-Pelagia Magiorakos, Arjun Srinivasan, Roberta B. Carey et al. · Clinical Microbiology and Infection Open access 7 May 2011 14,554
15 A new coronavirus associated with human respiratory disease in China Fan Wu et al. · Nature Open access 3 Feb 2020 12,967
16 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Roujian Lu et al. · The Lancet Open access 30 Jan 2020 12,621
17 Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors 23 Nov 2018 11,535
18 Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine Lindsey R. Baden et al. · New England Journal of Medicine Open access 30 Dec 2020 10,910
19 Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Xiaobo Yang, Yu Lai Yuan, Jiqian Xu et al. · The Lancet Respiratory Medicine Open access 24 Feb 2020 10,739
20 Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area Safiya I. Richardson et al. · JAMA Open access 22 Apr 2020 9,915
21 Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Daniel Wrapp, Nianshuang Wang, Kizzmekia S. Corbett et al. · Science Open access 19 Feb 2020 9,833
22 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Jasper Fuk‐Woo Chan et al. · The Lancet Open access 24 Jan 2020 9,628
23 Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection Frank Joseph Palella, Kathleen M. Delaney, Anne C. Moorman et al. · New England Journal of Medicine 26 Mar 1998 9,545
24 Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici et al. · Cell Open access 9 Mar 2020 9,155
25 Pathological findings of COVID-19 associated with acute respiratory distress syndrome Zhe Xu, Lei Shi, Yijin Wang et al. · The Lancet Respiratory Medicine Open access 18 Feb 2020 8,909
26 Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China Chaomin Wu et al. · JAMA Internal Medicine Open access 13 Mar 2020 8,770
27 Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1 Ahmad Almilaji, Kalina Szteyn, Evelyn Fein et al. · Cellular Physiology and Biochemistry Open access 2013 8,699
28 The serial cultivation of human diploid cell strains Leonard Hayflick, Paul S. Moorhead · Experimental Cell Research Dec 1961 8,548
29 Global trends in emerging infectious diseases Kate E. Jones, Nikkita Patel, Marc A. Levy et al. · Nature Open access Feb 2008 8,468
30 Extracellular vesicles: Exosomes, microvesicles, and friends Graça Raposo, Willem Stoorvogel · The Journal of Cell Biology Open access 18 Feb 2013 8,242
31 Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Victor M. Corman et al. · Eurosurveillance Open access 23 Jan 2020 8,218
32 A novel coronavirus outbreak of global health concern Chen Wang, Peter Horby, Frederick G. Hayden et al. · The Lancet Open access 24 Jan 2020 8,144
33 Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Stewart Thomas Cole et al. · Nature Open access Jun 1998 7,928
34 Enterotypes of the human gut microbiome Manimozhiyan Arumugam et al. · Nature Open access 19 Apr 2011 7,806
35 The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Alexander E. Gorbalenya, Susan C. Baker, Ralph Steven Baric et al. · Nature Microbiology Open access 2 Mar 2020 7,774
36 Remdesivir for the Treatment of Covid-19 — Final Report John H. Beigel et al. · New England Journal of Medicine Open access 22 May 2020 7,759
37 Foodborne Illness Acquired in the United States—Major Pathogens Elaine Scallan, Robert Michael Hoekstra, Frederick J. Angulo et al. · Emerging infectious diseases Open access 27 Dec 2010 7,709
38 Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China Ling Mao, Huijuan Jin, Mengdie Wang et al. · JAMA Neurology Open access 10 Apr 2020 7,427
39 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Manli Wang, Ruiyuan Cao, Leike Zhang et al. · Cell Research Open access 4 Feb 2020 7,401
40 Food-Related Illness and Death in the United States Paul S. Mead, Laurence Slutsker, VANCE J. DIETZ et al. · Emerging infectious diseases Open access Oct 1999 7,276
41 Virological assessment of hospitalized patients with COVID-2019 Roman Wölfel, Victor M. Corman, Wolfgang Guggemos et al. · Nature Open access Apr 2020 7,240
42 Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus Peter A. Banks, Thomas L. Bollen, Christos Dervenis et al. · Gut Open access 25 Oct 2012 7,229
43 Prevention of HIV-1 Infection with Early Antiretroviral Therapy Myron S. Cohen et al. · New England Journal of Medicine Open access 18 Jul 2011 7,006
44 Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome Qui‐Lim Choo, George C. Kuo, Amy J. Weiner et al. · Science 21 Apr 1989 6,911
45 Factors associated with COVID-19-related death using OpenSAFELY Elizabeth Williamson et al. · Nature Open access 8 Jul 2020 6,783
46 Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor Jun Lan, Jiwan Ge, Jinfang Yu et al. · Nature Open access 30 Mar 2020 6,769
47 CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting Teresa C Horan, Mary L. Andrus, Margaret A. Dudeck · American Journal of Infection Control Jun 2008 6,712
48 Endothelial cell infection and endotheliitis in COVID-19 Zsuzsanna Varga, Andreas J. Flammer, Peter Steiger et al. · The Lancet Open access 21 Apr 2020 6,667
49 The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application Stephen A. Lauer, Kyra H. Grantz, Qifang Bi et al. · Annals of Internal Medicine Open access 9 Mar 2020 6,618
50 First Case of 2019 Novel Coronavirus in the United States Michelle L. Holshue et al. · New England Journal of Medicine Open access 31 Jan 2020 6,413

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.